Filing Details

Accession Number:
0000899243-18-026091
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-03 17:50:59
Reporting Period:
2018-10-01
Accepted Time:
2018-10-03 17:50:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1740547 Urovant Sciences Ltd. UROV () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1290166 Qvt Associates Gp Llc 444 Madison Avenue, 21St Floor
New York NY 10022
No No Yes No
1543904 Qvt Fund V Lp 190 Elgin Avenue
George Town, Grand Cayman E9 KY1-9005
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Par Value $0.000037453 Per Share Acquisiton 2018-10-01 2,678,571 $14.00 22,703,669 No 4 P Indirect see fn
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect see fn
Footnotes
  1. QVT Financial LP, its general partner, QVT Financial GP LLC, QVT Family Office Fund LP (f/k/a QVT Fund V LP) and QVT Associates GP LLC, the general partner of QVT Family Office Fund LP (collectively, "QVT"), may be deemed to have beneficial ownership over the 22,703,669 Common Shares held by Roivant Sciences Ltd. ("Roivant") because, as shareholders of Roivant, QVT may be deemed to have dispositive power and, therefore, beneficial ownership, over the Common Shares held by Roivant by virtue of governance arrangements in Roivant's bye-laws. The filing of this statement shall not be deemed an admission that QVT is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. QVT expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.